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Norwalk virus (NoV) is responsible for most outbreaks of non-bacterial gastroenteritis. NoV
is genetically diverse and show antigenically variable. Recently, we produced a monoclonal
antibody called 5B-18 that reacts broadly with NoV genogroup II (GII). We suspected the
5B-18 binds to a conformational epitope on 3D structure of virion. X-ray crystallography
showed us that 5B-18 binds to NoV at the P domain, which protrudes from the capsid
surface of the virion. However, there seems to be no space that would allow the IgG to
approach the virion. To solve this problem, we used cryo-electron microscopy to examine
NoV GII virus-like particles (VLPs). The P domain rises up higher in NoV GII than in NoV
GI, and it seems to form an outer layer around the virion. Finally, using in silico modeling
we found the 5B-18 Fab arms and NoV P region are quite ﬂexible, so that 5B-18 can
bind the NoV virion from bottom of P domain. This study demonstrates the shortcomings
of studying biological phenomenon by only one technique. Each method has limitations.
Multiple methods and modeling in silico are the keys to solving structural problems.
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THE BASICS OF NORWALK VIRUS
Norwalk virus (NoV) is responsible for most of the outbreaks
of non-bacterial gastroenteritis in developed countries and, it is
thought, in developing countries as well. Yet, although NoV was
identiﬁed more than 30 years ago, we know little about their
pathogenicity and basic virology (Guix et al., 2007). Studies of
NoV have been hampered by the lack of a cell-culture system
or a small animal model in which the virus will grow, except
murine norovirus that is classiﬁed as NoV genogroup V (Wobus
et al., 2006).
NoV belongs to the family Caliciviridae. The genus Norovirus
has only one species, Norwalk viruses, with ﬁve genogroups (GI–
GV). Genogroup GI and II cause most human infections, and
they are further subdivided into numerous genotypes (GI.1–8 and
GII.1–17; Zheng et al., 2006). The NoV genome is a 7.3 to 7.7-kb
positive-sense, polyadenylated, single-stranded RNA molecule. It
contains three open reading frames (ORFs): ORF1 encodes a non-
structural polyprotein, and ORF2 and ORF3 encode the major
and minor capsid proteins, VP1 andVP2, respectively (Jiang et al.,
1992; Lambden et al., 1993).
Without an in vitro system for propagating the virus, the
antigenicity of NoV has been inferred from studies of virus-like
particles (VLPs). Nucleic acid-free VLPs self-assemble when the
capsid protein is expressed in a baculovirus expression system
(Figure 1A). The VLPs are assumed to have a similar morphology
and, thus, antigenicity as that of the native virions (Jiang et al.,
1992). Cryo-electron microscopy (cryo-EM) and x-ray crystal
structures of the prototype norovirus VLP (GI.1, Norwalk virus)
showed that the VLPs form a T = 3 icosahedral structure (Prasad
et al., 1994, 1999).
However, structures of large protein complexes are difﬁcult
to determine by x-ray analysis. We sought to understand the
structure of the virion and how it interacts with antibodies by
combining data from x-ray diffraction, cryo-EM, and in silico
modeling.
A MONOCLONAL ANTIBODY REACTS BROADLY
WITH NoV GII
NoV is generally detected by RT-PCR with degenerate primers
or an ELISA with NoV-speciﬁc antibodies. Many polyclonal
and monoclonal antibodies used in the ELISA kits were devel-
oped inmice or rabbit immunizedwith norovirusVLPs (Hansman
et al., 2011).
Recently, we produced a monoclonal antibody called 5B-18
that reacts broadly with NoV GII (Hansman et al., 2012). In fact,
5B-18 is used as a NoV GII broad-range capture antibody in a
commercial ELISA kit [NV-AD(III) SEIKEN NoV antigen ELISA]
and in an immunochromatography (IC) kit (Quick naviNoro IC
kit, both from Denka-Seiken, Japan).
The 5B-18 monoclonal antibody was produced by immunizing
amousewith norovirusVLPs. Severalmonoclonal antibodies bind
to the shell (S) domain (Yoda et al., 2003; Li et al., 2010), and others
bind to the protruding (P) domain (Lindesmith et al., 2012). We
suspect that 5B-18 also binds to S or P domain on the surface
of the NoV virion. However, no high-resolution structural details
of the antibody binding to the VLPs, S domain or P domain are
available.
X-RAY CRYSTALLOGRAPHY OF THE BINDING SITE
The 5B-18 binds major NoV genotypes, such as GII.4 and GII.3,
and the minor NoV genotypes GII.10 and GII.12 strongly. We
suspect 5B-18 binds to a conserved epitope on the NoV capsid
surface. We wanted to deﬁne the recognition site of 5B-18 and the
NoV minor genotype GII.10 P domain, and we began with x-ray
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FIGURE 1 |The cryo-EM image of GII.10VLP and the P dimer structure
fit to the cryo-EM image by in silico modeling.The cryo-EM structure
of NoV GII.10 VLP was constructed with 180 molecules of VP1 protein
(A). The cross-section of GII.10 VLP (B). P domains (blue and green) rise
up from shell domain (yellow), and it seemed to construct an outer layer
of the capsid. Diagram based on the x-ray crystal structure of the GII.10 P
domain-Fab complex shows Fab bound to the lower side of the P1 sub
domain. Top side indicates the outside of the VLP, and the shell side
contains the VLP core that is called shell. A white arrow indicates the
GII.10 P dimer; the monomer is colored blue and purple. Black arrow shows
MoAb 5B-18 Fab region. Green represents the heavy chain, and yellow
represents the kappa chain. The part of oval shadow represents VLP shell
(C). The x-ray crystallography was ﬁt into the cryo-EM structure by in silico
modeling (D). The GII.10 P domain (apo P domain structure) into the A/B
dimer subunit (light blue and pink, respectively) and C/C dimer
subunit (cyan).
crystallography, one of the gold standard for protein structural
studies. We expressed the NoV GII.10 P domain in the Escherichia
coli strain BL21 (DE3). The P domain was puriﬁed and stored
in gel ﬁltration buffer. Next we prepared of 5B-18 Fab fragment
by immunizing a mouse with NoV GII.4-strain 445 VLPs (Gen-
Bank accession number DQ093064; Denka-Seiken, Japan). To
prepare crystals of the bound complex, puriﬁed GII.10 P domain
and Fab were mixed in a 1.4:1 ratio. Crystals were grown by the
hanging-drop vapor-diffusion method, mixing the protein and
reservoir solution (40% [vol/vol] polyethylene glycol [PEG] 400,
5% [wt/vol] PEG 3350, and 0.1 M acetic acid, pH 5.5) in a 1:1
ratio. Crystals grew over 1 week at 20◦C.
OneGII.10 P domain-Fab complex crystal diffracted x-rays to a
resolution 3.3Å, and we solved the structure by molecular replace-
ment with a GII.10 P domain monomer (PDB ID 3ONU) and a
mouse Fab (PDB ID 1WEJ) as search models. Molecular replace-
ment indicated an asymmetrical unit contained two P domain
monomers and two 5B-18 Fabs, each with a kappa and a heavy
chain (Figure 1C; Hansman et al., 2012).
The binding of the P domain and the Fab involved nine hydro-
gen bonds. Of these, eight linked the P1 subdomain to the kappa
chain, and one linked the P1 subdomain and the heavy chain.
More speciﬁcally, the amino acids in the P1 subdomain amino
acids that interacted with the 5B-18 Fab were as follows (in each
pair, the amino acids are for the P1 domain and Fab, respectively):
Tyr533 and Tyr92 (one bond), Thr534 and Gly93 (three bonds),
Thr534 and Trp97 (one bond), Leu535 and Tyr32 (one bond),
Glu496 and Tyr92 (one bond), and Asn530 and Ser94 (one bond).
Finally,Val433 andAsn52 in the heavy chain formed one hydrogen
bond (Hansman et al., 2012).
CONFIRMATION OF 5B-18 BINDING
With the x-ray crystallographic analysis, we found the 5B-18 anti-
body bound to a hidden site on the P domain that is located inside
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of the shell of NoV particle. However, in a previous study, the NoV
GI structure indicated that bottomof the Pdomainwas completely
covered by the shell of NoVparticle (Figure 1C). If the structure of
GII is the same as GI, then 5B-18 could not bind GII. These results
presented an apparent paradox for the 5B-18 binding mechanism.
To resolve the paradox, we set out to identify the binding residue
in the capsid.
From the crystallographic analysis, we knew that the 5B-18
Fab formed hydrogen bonds with residues at three sites in the
P1 subdomain, called A, B, and C (Figure 2A). By aligning the
amino acid sequences of representatives from NoV GII genotypes,
we discovered that Val433 (site A) was the most variable. Other
genotypes had threonine, serine, asparagine, leucine, or methio-
nine at this position. Thr534 (site C) was mostly conserved: the
only other amino acid at this position was a serine. Glu496 (site
B), Asn530 (site C), Tyr533 (site C), and Leu535 (site C) were all
highly conserved among the representative GII genotypes.
To conﬁrm that 5B-18 binds theA, B, and C regions, we divided
the GII.10 capsid domain into three major subdomains: N, S, P1-1
P2, and P1-2.We prepared ﬁve constructs (1–5), expressed them in
an E. coli expression system, and identiﬁed a liner epitope of 5B-18
by western blotting (Figure 2B). Construct 3, a P1-2 region (i.e.,
A,B,andC), showed the strongest band signal, and construct 5 (i.e.,
B and C) showed a positive band. The intensity of the band from
construct 5 was only about half the strength of construct 3 because
it did not contain epitopeA.However, construct 4 included onlyA,
and constructs 1 and 2 also were not detected. Thus, the three 5B-
18 epitopes A, B, and C were conﬁrmed to be part of the binding
epitope.
Next, we determined if 5B-18 binds to other NoV GII VLPs
(Figure 2A). We prepared and puriﬁed six kinds of GII VLPs that
were 809 (GII.3), 104 (GII.4), 445 (GII.6), 026 (GII.10), Hiro
(GII.12), and GII.13 VLPs as aligned in Figure 2A. The GII VLPs
that had all 5B-18 epitopes A, B, and C were captured by the anti-
GII VLPs rabbit serum that was pre-coated on ELISA plate and
detected with 5B-18 and horseradish peroxidase (HRP)-labeled
anti-mouse IgG secondary antibodies. When the cut-off value
was under 0.2, 5B-18 detected all kinds of GII VLPs in a dose-
dependent manner (data not shown). These results suggested that
5B-18 binds to a variety of GIIVLPs. In fact, the commercial ELISA
and IC kits use 5B-18 (Denka-Seiken, Japan), and we have practi-
cal results showing that 5B-18 detects various infectious NoV GII
in stool samples.
COMBINING CRYO-EM AND IN SILICO MODELING
TO SOLVE A PARADOX
We had a simple question. Are the structures of NoV GI VLP and
GII VLP the same or not? For G1 VLP, there is no space where
the 5B-18 can access and bind the bottom of P domain. If the
GII VLP had same conformation as the GI VLP, the lower part of
the P domain would be buried under the virion shell (Figure 1C).
However, 5B-18 binds and detects GII VLPs and GII infectious
viruses. These conﬂicting facts suggested that the structures of the
GIIVLPs and infectious GII virions were different than theGIVLP
structure. However, structure determinations by x-ray crystallog-
raphy havemany challenges and limitations, and we suspected this
might be one of those cases.
To answer the question, we turned to cryo-EM and in silico
modeling. We reconstructed the overall structure of GII.10 VLPs
and 5B-18 Fabs from the x-ray structural data. To determine if
the GII VLP had enough space to allow binding, we also used in
silico modeling to ﬁt the P and 5B-18 Fabs structures that had been
derived by x-ray crystallography.
The GII.10 VLPs formed homogeneous, monodisperse parti-
cles in ice. By reference-free class averages and at 10Å resolution
(0.5 FSC criterion), these icosahedral particles had several notable
features, including spike-like structures extending from the ver-
tices (Figure 1B), and at the three- and ﬁvefold axes, signiﬁcant
amounts of the surface of the S domain were exposed (Figure1A).
The GII.10 VLP P domain formed a second outer shell that seems
to be separated from the S domain by about 15Å (Figure 1B).
Thus, unlike the GI VLPs and virions, GII VLPs and virions seem
to have a space between the shell and bottom of P domain, indicat-
ing that the two genotypes have different structures. Furthermore,
the electron density was much weaker at the tip of the P domain
(the P2 subdomain) than at the base. This observation is consis-
tent with published reconstructions of calicivirus particles (Bhella
et al., 2008; Bhella and Goodfellow, 2011) and indicates that the P
domains have considerable heterogeneity.
Next we attempted to ﬁt the GII.10 P domain and P domain-
Fab complex structures into the GII.10 VLP cryo-EM structure.
At 10Å resolution, the GII.10 P domain monomers in the VLP
were easily distinguished. We manually ﬁtted the crystal struc-
tures of the GII.10 P domain and P domain-Fab complex into
the GII.10 VLP cryo-EM map, using published reports of GV.1 P
domain dimers and the GV.1 cryo-EM map (Taube et al., 2010) as
guides.
We reﬁned the approximate alignment with the Fit-in-Map
function in UCSF Chimera (Pettersen et al., 2004) to a cross-
correlation coefﬁcient of 0.94 (Figure 1D) with excellent results.
The x-ray structure of theGII.10 Pdomain dimer (PDB ID3ONU)
unambiguously ﬁtted the corresponding density in the cryo-EM
map (Figure 1D). Only some loops of the P2 subdomain did not
ﬁt. They had only weak electron density, and their tips were less
ordered than the S domain and P1 domains in the cryo-EM recon-
struction. These subdomains are probably more ﬂexible. P1, but
not the P2, subdomains in the VLP appeared to be connected to
the P domain dimers.
Next we ﬁtted the x-ray structure of the P domain from the P
domain-Fab complex into the reconstructed A/B dimer subunit
and found that the 5B-18 binding site was close to an adjacent
dimer of P domain (Figure 1C). At the twofold axes, the 5B-18
Fabwas hindered by the S domain,which also provided an obstacle
to assembly of the neighbor P domain dimer. However, when the
P domain was ﬁtted into the C/C dimer subunit, the 5B-18 Fab
was in contact with the P domain dimer and slightly interfered
with part of the S domain at the ﬁvefold axes. Thus, the antibody
binding site overlapped with part of the P1 subdomain.
Thus, this model predicted an unstable structure in which the
VLP could not bind with the 5B-18 antibodies. How could this
be? There are several possibilities. First, 5B-18 might bind at sites
on the P domain that are only transiently exposed. Second, 5B-18
might bind to defects in the P domain. Finally, the Fab arms of
5B-18 might be very ﬂexible.
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FIGURE 2 | Schematic diagram of NoVVP1 protein and the amino
acid alignment of NoV GIIVP1 sequences. Capsid (VP1) sequences from
11 GII genotypes were aligned, and the GII.10 capsid sequence was
used as the consensus. The GII.10 P domain residues that interacted with
the 5B-18 Fab involved three sites on the P domain termed A, B, and C.
The six GII.10 P domain residues that interacted with the 5B-18 Fab are
indicated by light blue rectangles (A). Left panel of (B): a schematic
of the VP1 deletion mutants. The construct 1 includes the N-terminal
region and shell domain of VP1, and amino acids 4–223 from the
N-terminal methionine of VP1. The P1-1 and P2 domain constructs without
binding site A are construct 2 (amino acids 224–426), with binding site
A is construct 4 (amino acids 224–439). Construct 3 has all binding sites
A, B and C (amino acids 427–548). Construct 5 deletes binding site A
from construct 3 (amino acids 440–548). Right panel of (B): western
blotting results with 5B-18. Samples indicated as VLP, NC (negative control),
mutant construct 1 (#1), #2, #3, #4 and #5. The black arrow represents VLP
band at 58 kDa, and the white arrows represent #3 and #5 products
at 13 kDa.
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IgG ﬂexibility is not unknown. For example, a neutralizing
antibody 9C12 binds to hexon, the major coat protein of aden-
ovirus, at a ratio of 240 antibody molecules to one virus particle
or one antibody per hexon trimer (Varghese et al., 2004). By
dynamic light scattering and negative-stain EM, electron-dense
material coats the virus, but it was not aggregated at neutralizing
ratios. In images reconstructed from cryo-EM, the viral surface
was covered by electron density from the 9C12 antibody. Two
Fab arms bridge two peripentonal hexons. One has a normal
Fab shape and ﬁtted the models well (Harris et al., 1998). The
other arm has a somewhat distorted structure. A low-density tail
extends to a third hexon that forms a minor alternate binding
site. The normal arm binds to a unique site in the asymmet-
ric unit of the virus. It has no alternate binding sites because
a penton, rather than a hexon, is positioned at the icosahedral
ﬁvefold axis. In addition, the angle between the long axes of the
Fabs was<115◦ that was found in the uncomplexed IgG1 (Harris
et al., 1998). Thus, ﬂexibility is important for the bivalent binding
of 9C12.
ESTIMATING THE FLEXIBILITY IN THE STRUCTURE
The ﬁndings from the 9C12 study were informative for our 5B-18
paradox. 5B-18 could reach the bottom of the P domain if the
Fab domain could bend and escape the P1 subdomain or star-like
structure on the shell. 5B-18 IgG bound equally well with intact
and partially broken GII.10 VLPs. To determine if 5B-18 binds to
intact or broken particles, we took advantage of a characteristic
of norovirus VLPs: they are less stable and appear to be broken
at high pHs (Ausar et al., 2006). Therefore, we looked at 5B-18
binding at different pHs. At low and neutral pHs (5.3, 6.3, and
7.3), the GII.10VLPs were mostly homogenous in size and unbro-
ken, but at higher pHs (8.3 and 9.3), they were less homogenous
and partially broken. 5B-18 IgG bound to GII.10 VLPs at different
pH values with nearly identical efﬁcacies, regardless of the fraction
of damaged particles. At pH 5.3, 6.3, and 8.3, the titer was 512,000.
At pH 9.3, it was 1,024,000, and at pH 7.3, it was 2,048,000 (optical
density cutoff of 0.2; Hansman et al., 2006). We also determined
size distribution of the VLPs by dynamic light scattering in each
pH conditions. VLPs were shown single peak on diameter 38 to
50 nm (data not shown). These results suggest that 5B-18 appears
detects nominally intact GII.10 VLPs.
We studied the 5B-18 binding mechanism by x-ray crystallog-
raphy, molecular virology, and cryo-EM. We combined the results
in in silico modeling that simulates molecular dynamics and is
a reliable method for revealing ﬂuctuations in protein structure.
Each technique complemented the other by ﬁlling in for data that
was lacking from the others. Interestingly, the 5B-18 study sug-
gests that VLP and viral virion have structure ﬂexibility and that
IgG molecule have ﬂexible arms. They co-work each other and
bind. In silico modeling is clearly a powerful tool for enhancing
our understanding of basic viral processes.
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